CBD and Atomoxetines (e.g. Strattera, Attentin)

medication pills

As the popularity of cannabidiol (CBD) continues to rise, many individuals who are currently on medications, such as Atomoxetine, are considering adding CBD to their regimen. However, it's important to understand the potential interactions and side effects that may occur. This article aims to provide a clear and unbiased overview of the potential interactions between CBD and Atomoxetine-based medications, commonly known as Strattera and Attentin.

Understanding CBD and Atomoxetine

What is CBD?

CBD, short for cannabidiol, is a natural compound found in hemp plants. It's known for its potential therapeutic benefits, which include pain relief, anxiety reduction, and improved sleep, among others. CBD works by interacting with the endocannabinoid system (ECS), a complex cell-signaling system in the body that plays a role in regulating a wide array of functions and processes, including sleep, mood, appetite, and memory.

What is Atomoxetine?

Atomoxetine, sold under the brand names Strattera and Attentin, is a medication primarily used to treat attention deficit hyperactivity disorder (ADHD). It works by increasing the levels of norepinephrine, a neurotransmitter in the brain, which helps in reducing impulsive behavior and improving attention span.

Common Brand Names of Atomoxetine-Based Medications

Atomoxetine is marketed under various brand names across the globe. Here are some of the most common ones:

  • Strattera - commonly used in the United States, Canada, and the UK
  • Attentin - commonly used in Sweden and other European countries
  • Tomoxetin - commonly used in several Middle Eastern countries
  • Axepta - commonly used in India

Potential Interactions Between CBD and Atomoxetine

Both CBD and Atomoxetine are metabolized by enzymes in the liver, specifically the cytochrome P450 enzymes. This means they could potentially interact with each other. Studies have shown that CBD can inhibit these enzymes, potentially leading to higher levels of Atomoxetine in the body. This could increase the side effects of Atomoxetine, which include nausea, dry mouth, decreased appetite, and dizziness.

However, it's important to note that while these potential interactions have been identified, the research on CBD and its interactions with other drugs is still in its early stages. Therefore, the full extent of these interactions is not yet fully understood.

Consulting with a Healthcare Provider

Given the potential for interactions between CBD and Atomoxetine, it's crucial to consult with a healthcare provider before adding CBD to your regimen. They can provide personalized advice based on your current medications and overall health status. Remember, while CBD may have potential health benefits, it should not be used as a substitute for prescribed medication unless advised by a healthcare provider.


In conclusion, while CBD has potential health benefits, it may interact with Atomoxetine-based medications like Strattera and Attentin. This interaction could potentially lead to an increase in the side effects of Atomoxetine. Therefore, it's important to consult with a healthcare provider before adding CBD to your regimen. As the research on CBD and its potential drug interactions continues to evolve, staying informed and consulting with healthcare professionals will be key to safe and effective use.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.